Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.

A pragmatic randomized waitlist-controlled effectiveness and cost-effectiveness trial of digital interventions for depression and anxiety

Open access

Abstract

Utilization of internet-delivered cognitive behavioural therapy (iCBT) for treating depression and anxiety disorders in stepped-care models, such as the UK’s Improving Access to Psychological Therapies (IAPT), is a potential solution for addressing the treatment gap in mental health. We investigated the effectiveness and cost-effectiveness of iCBT when fully integrated within IAPT stepped-care settings. We conducted an 8-week pragmatic randomized controlled trial with a 2:1 (iCBT intervention: waiting-list) allocation, for participants referred to an IAPT Step 2 service with depression and anxiety symptoms (Trial registration: ISRCTN91967124). The primary outcomes measures were PHQ-9 (depressive symptoms) and GAD-7 (anxiety symptoms) and WSAS (functional impairment) as a secondary outcome. The cost-effectiveness analysis was based on EQ-5D-5L (preference-based health status) to elicit the quality-adjust life year (QALY) and a modified-Client Service Receipt Inventory (care resource-use). Diagnostic interviews were administered at baseline and 3 months. Three-hundred and sixty-one participants were randomized (iCBT, 241; waiting-list, 120). Intention-to-treat analyses showed significant interaction effects for the PHQ-9 ( b = −2.75, 95% CI −4.00, −1.50) and GAD-7 ( b = −2.79, 95% CI −4.00, −1.58) in favour of iCBT at 8-week and further improvements observed up to 12-months. Over 8-weeks the probability of cost-effectiveness was 46.6% if decision makers are willing to pay £30,000 per QALY, increasing to 91.2% when the control-arm’s outcomes and costs were extrapolated over 12-months. Results indicate that iCBT for depression and anxiety is effective and potentially cost-effective in the long-term within IAPT. Upscaling the use of iCBT as part of stepped care could help to enhance IAPT outcomes. The pragmatic trial design supports the ecological validity of the findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41746-020-0293-8

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flowchart of participants – CONSORT. CBT Cognitive Behavioural Therapy; GSH Guided Self-Help; MINI Mini International Neuropsychiatric Interview 7.0.2 (M.I.N.I.7.0.2); PHQ-9 Patient-Health Questionnaire-9; GAD-7 Generalised Anxiety Disorder-7; S2 Step 2 IAPT; S3 step 3 IAPT; PWP Psychological Wellbeing Practitioners; TS1 Telephone Screening 1.
Fig. 1 Flowchart of participants – CONSORT. CBT Cognitive Behavioural Therapy; GSH Guided Self-Help; MINI Mini International Neuropsychiatric Interview 7.0.2 (M.I.N.I.7.0.2); PHQ-9 Patient-Health Questionnaire-9; GAD-7 Generalised Anxiety Disorder-7; S2 Step 2 IAPT; S3 step 3 IAPT; PWP Psychological Wellbeing Practitioners; TS1 Telephone Screening 1.CC BY · PubMed Central
Fig. 2 Estimated marginal means and confidence intervals (CI) for time by treatment group interaction effects at 8-weeks. a Random intercept linear mixed model suggesting significant time by intervention-arm interaction effect. Bonferroni adjusted estimated mean difference between intervention-arms at 8-weeks 2.52 (95% CI 0.78, 4.27, p = 0.0009). Between group effect size d = 0.55 (95% CI 0.32, 0.77). b Random intercept linear mixed model suggesting significant time by intervention-arm interaction effect. Bonferroni adjusted estimated mean difference between intervention-arms at 8-weeks 2.67 (95% CI 1.07, 4.26, p = 0.0001). Between group effect size d = 0.63 (95% CI 0.40, 0.85). c Random intercept linear mixed model suggesting significant time by intervention-arm interaction effect. Bonferroni adjusted estimated mean difference between intervention-arms at 8-weeks 4.68 (95% CI 2.11, 7.24, p < 0.0001). Between group effect size d = 0.35 (95% CI 0.13, 0.57).
Fig. 2 Estimated marginal means and confidence intervals (CI) for time by treatment group interaction effects at 8-weeks. a Random intercept linear mixed model suggesting significant time by intervention-arm interaction effect. Bonferroni adjusted estimated mean difference between intervention-arms at 8-weeks 2.52 (95% CI 0.78, 4.27, p = 0.0009). Between group effect size d = 0.55 (95% CI 0.32, 0.77). b Random intercept linear mixed model suggesting significant time by intervention-arm interaction effect. Bonferroni adjusted estimated mean difference between intervention-arms at 8-weeks 2.67 (95% CI 1.07, 4.26, p = 0.0001). Between group effect size d = 0.63 (95% CI 0.40, 0.85). c Random intercept linear mixed model suggesting significant time by intervention-arm interaction effect. Bonferroni adjusted estimated mean difference between intervention-arms at 8-weeks 4.68 (95% CI 2.11, 7.24, p < 0.0001). Between group effect size d = 0.35 (95% CI 0.13, 0.57).CC BY · PubMed Central
Fig. 3 Intervention-arm estimated marginal means and confidence intervals (CI) across all time-points (in months). a Marginal linear model showing estimated mean PHQ-9 score reductions across all timepoints. Bonferroni adjusted estimated mean difference between 8-weeks and (i.e. 2 months) and 12-months 3.12; SE = 0.44; 95% CI 1.82, 4.39; p < 0.0001). b Marginal linear model showing estimated mean PHQ-9 score reductions across all timepoints. Bonferroni adjusted estimated mean difference between 8-weeks and (i.e. 2 months) and 12-months 2.60; SE = 0.40; 95% CI 1.43, 3.76; p < 0.0001). c Marginal linear model showing estimated mean PHQ-9 score reductions across all timepoints. Bonferroni adjusted estimated mean difference between 8-weeks and (i.e. 2 months) and 12-months 3.24; SE = 0.62; 95% CI 1.40, 5.07; p < 0.0001).
Fig. 3 Intervention-arm estimated marginal means and confidence intervals (CI) across all time-points (in months). a Marginal linear model showing estimated mean PHQ-9 score reductions across all timepoints. Bonferroni adjusted estimated mean difference between 8-weeks and (i.e. 2 months) and 12-months 3.12; SE = 0.44; 95% CI 1.82, 4.39; p < 0.0001). b Marginal linear model showing estimated mean PHQ-9 score reductions across all timepoints. Bonferroni adjusted estimated mean difference between 8-weeks and (i.e. 2 months) and 12-months 2.60; SE = 0.40; 95% CI 1.43, 3.76; p < 0.0001). c Marginal linear model showing estimated mean PHQ-9 score reductions across all timepoints. Bonferroni adjusted estimated mean difference between 8-weeks and (i.e. 2 months) and 12-months 3.24; SE = 0.62; 95% CI 1.40, 5.07; p < 0.0001).CC BY · PubMed Central
Fig. 4 CEAC representing probability of cost-effectiveness of iCBT relative to waiting-list control over 8 weeks, and predicted over 6, 9, and 12 months. ITT Intention-to-treat, BA Baseline-Adjusted; QALY Quality-Adjusted Life year.
Fig. 4 CEAC representing probability of cost-effectiveness of iCBT relative to waiting-list control over 8 weeks, and predicted over 6, 9, and 12 months. ITT Intention-to-treat, BA Baseline-Adjusted; QALY Quality-Adjusted Life year.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 1

  1. Layard, R. & Clark, D. Thrive: The Power of Evidence-based Psychological Therapies (Penguin, UK, 2014).

Cited by

See all 154

Metadata

Authors
Richards, D., Enrique, A., Eilert, N., Franklin, M., Palacios, J., Duffy, D., Earley, C., Chapman, J., Jell, G., Sollesse, S., & Timulak, L.
Affiliations
  • Trinity College Dublin (IE)
  • University of Sheffield (GB)
  • Berkshire Healthcare NHS Foundation Trust (GB)
Corresponding author
Richards, Derek
Venue
npj Digital Medicine
Published
2020-06-15
Volume
3
Issue
1
Pages
85-85
ISSN
2398-6352 (ISSN-L)
OpenAlex
W3035328635
Cited by
154
References
41
Citations by year
2026: 20 · 2025: 26 · 2024: 20 · 2023: 31 · 2022: 33 · 2021: 17 · 2020: 7
FWCI
19.88
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Digital Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion, cc-by)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
Funders
  • SilverCloud Health
  • Berkshire Healthcare NHS Foundation Trust
Topics
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
internet-based cognitive behavioral therapy, depression, anxiety, Improving Access to Psychological Therapies, cost-effectiveness, digital mental health interventions, quality-adjusted life years, functional disability, waitlist control

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A pragmatic randomized waitlist-controlled effectiveness and cost-effectiveness trial of digital interventions for depression and anxiety. https://app.cochat.ai/papers/10.1038/s41746-020-0293-8
The paper
Richards, D., Enrique, A., Eilert, N., Franklin, M., Palacios, J., Duffy, D., Earley, C., Chapman, J., Jell, G., Sollesse, S., & Timulak, L. (2020). A pragmatic randomized waitlist-controlled effectiveness and cost-effectiveness trial of digital interventions for depression and anxiety. npj Digital Medicine. https://doi.org/10.1038/s41746-020-0293-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.